Aktienkurs
9.32
Täglich Wechseln
0.31 3.44%
Monatlich
-6.80%
Jährlich
-7.45%
Q2 Prognose
8.82




SCHULD Veränderung Datum
Avita Medical AUD 46.05M 1.46M 2025-12
Medical Developments International AUD 1.99M 152K 2025-06
Mesoblast USD 128.16M 9.23M 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Pacific Edge NZD 2.9M 425K 2025-03
Paradigm Biopharmaceuticals AUD 181.4K 38.99K 2024-12
PYC Therapeutics AUD 1.02M 185.07K 2025-06
Telix Pharmaceuticals AUD 418.25M 163.2M 2025-06